Semiconductor giant Marvell Technology Inc (NASDAQ:MRVL) shared better-than-expected fourth-quarter earnings and revenue earlier, but also issued a lackluster fiscal first-quarter guidance. Below, let's dig into the implications of this update on both the equity and its sector peers, Texas Instruments Inc (NASDAQ:TXN) and Micron Technology Inc (NASDAQ:MU).

MRVL Attracts Bear Notes

MRVL is up 17.8% at $74.11 at last glance, looking to extend its 33.8% year-to-date deficit with its biggest single-day percentage loss since January. Shares are trading at their lowest level since October as they break below the 200-day moving average, with several analysts chiming in with bear notes. No fewer than 11 firms slashed their price objectives, including Morgan Stanley to $90 from $113.

TXN Pacing for Weekly Drop

Last seen down 3.5% to trade at $188.76, TXN is well on its way to a weekly loss. The stock still sports a 10.6% year-over-year lead as it extends a pullback from a February peak above $205 -- their highest mark since November. Shares are today testing their 20-day moving average, which emerged as a support level last month.

MU Eyes 3rd-Straight Loss

MU is down 4.6% to trade at $90 at last check, pacing for its third-straight weekly loss. The security carries a 30.7% nine-month deficit, but a floor at the $87.50 level that contained several pullbacks so far this year, lingers below.

The Dow Jones Industrial Average (DJI) and Nasdaq Composite (IXIC) are both down triple digits this afternoon, with the S&P 500 Index (SPX) trailing behind as well. This downbeat sentiment comes despite the White House suggesting one-month tariff exemptions beyond the auto sector would be likely. In addition to the latest jobs data, investors are sifting through the Federal Reserve's Beige Book as well as the Institute for Supply Management’s (ISM) manufacturing index, both which point toward fears of higher input costs due to tariffs.

Continue reading for more on today's market, including: 

• Zscaler's beat-and-raise attracts bull notes.
• Weak guidance pressures MongoDB stock.
• Plus, options traders swarm CORZ; Mosaic stock extends bounce; and VSTR's pullback.

Core Scientific Inc(NASDAQ:CORZ) stock is getting blasted in the options pits today, with 109,000 calls and 57,000 puts exchanged so far, or 5 times the volume typically seen at this point. The most popular contract is the weekly 3/7 9.50-strike call, where positions are being opened. CORZ was last seen down 10.4% at $8.60, and earlier slipped to its lowest level since August after Microsoft (MSFT) withdrew some of its commitment to Coreweave. Core Scientific is planning a $1.2 billion data center expansion with the latter. Shares still sport a 118% year-over-year lead, however.

Tech stock Mosaic Co (NYSE:MOS) is leading the SPX today, last seen up 4.2% to trade at $24.92, rising alongside fertilizer peers as the sector looks likely to benefit from the tariff reprieve. The equity is extending a bounce off its March 4, four-year low of $22.49. Today's pop has MOS swinging to the positive side of its year-to-date breakeven level, but it still carries a 20.9% year-to-date deficit.

Vistra Corp (NYSE:VST) is at the bottom of the SPX, down 5.1% to trade at $120.35 at last glance, though a catalyst for today's negative price action remains unclear. Shares still boast a 97.4% year-over-year lead, while long-term support at the 200-day moving average looks poised to contain this pullback. The equity has a strong start to 2025, securing a Jan. 23, record high of $199.84 before gapping lower.

Retail stock Macy's Inc (NYSE:M) is down 1.9% at 13.05, earlier hitting a 52-week low of $12.60. The company reported mixed fourth-quarter results, including better-than-expected earnings alongside a revenue miss, but investors are focusing in on the disappointing full-year guidance. Notably, CEO Tony Spring's turnaround efforts appear to be taking shape, however, with comparable sales up 0.2% -- the highest since the first quarter of 2022. 

On the charts, the $16 level has been keeping rallies in check since early January. Should today's losses hold, M will only have closed one positive session since the stock was rejected there on Feb. 20. Year over year, the equity is down 33%. 

Analysts have yet to chime in, but over in the options pits, 19,000 calls and 11,000 puts have been exchanged, which is five times the overall options volume typically seen at this point. The weekly 3/7 13.50-strike call is the most popular, with new positions being opened there. 

Calls were more popular than usual over the past 10 weeks, too. M's 50-day call/put volume ratio of 3.82 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) ranks higher than 92% of readings from the past year. 

Zscaler Inc (NASDAQ:ZS) stock is up 5.2% to trade at $206.63 at last check, after the cloud company shared better-than-expected results for its fiscal second quarter and lifted its full-year outlook. Analysts are chiming in, with Rosenblatt Securities upgrading the stock to "buy" from "neutral," and raising its price target to $235 from $190. Another 11 firms lifted their price objectives as well.

Coming into today, 12 of the 39 firms in coverage called ZS a "hold" or worse, indicating there's still room for upgrades. The security also looks ripe for a short squeeze, with short interest up 28.4% over the last two reporting periods, making up 6.1% of its available float.

ZS is today pacing for its third-straight daily gain and looking to add to its 25% six-month lead. Shares could conquer overhead pressure at their 60-day moving average as they stage a bounce off the $185 level, which acted as resistance for most of January.

At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), ZS sports 50-day call/put volume ratio ratio of 2.99 that ranks higher than 96% of annuals readings. This suggests a strong bullish bias in the options pits.

Straight out of the gate, 18,000 calls and 11,000 puts have exchanged hands, 5 times the intraday average volume. Positions are being sold to open at most popular contract, the weekly 3/7 210-strike call.

Shares of MongoDB Inc (NASDAQ:MDB) were last seen down 23.5% at $202.19, after the database software company issued weaker-than-expected guidance for fiscal 2026. While fourth-quarter adjusted earnings topped analyst expectations, the company’s outlook for the year ahead fell short, now projecting adjusted EPS between $2.44 and $2.62, well below the $3.38 per share analysts had forecasted. Revenue projections also missed expectations, with MongoDB guiding for $2.24 billion to $2.28 billion, under the $2.32 billion consensus estimate.

The stock is now trading at its lowest level since April 2023 and is on track for its biggest single-day percentage drop since May 2024. Year-to-date, MDB has shed 12%, while its 50% year-over-year decline reflects mounting pressure from short- and long-term moving averages.

In response, Keybanc downgraded the stock to "sector weight" from "overweight," while at least 16 analysts slashed their price targets, including Scotiabank to $240. More price target cuts and downgrades could follow, given that the 12-month average price target of $364.09 still represents an 80% premium to MongoDB's current level, and 27 analysts maintain a "buy" or better rating.

Options traders are also piling on, with 14,000 calls and 22,000 puts already exchanged -- 18 times the stock’s average daily options volume. The March 210 put is seeing the most activity, while new positions are opening at the June 170 put, signaling bearish sentiment in the near term.

Satellite designer AST SpaceMobile Inc (NASDAQ:ASTS) announced better-than-expected fourth-quarter earnings and revenue after Tuesday's close. Today, the stock attracted three price-target hikes, including one from Deutsche Bank to $64 from $53. Below, let's see how ASTS and sector peers Rocket Lab USA Inc (NASDAQ:RKLB) and Intuitive Machines Inc (NASDAQ:LUNR) are faring.

ASTS Looks to Extend Impressive Lead

ASTS is up 15.1% at $32.93 at last glance, extending its already jaw-dropping 997.3% year-over-year lead. In 2025 alone, the equity already added 57%, and is now trading within striking distance of its highest level since September, after bouncing off support from the 40-day moving average.

Time to Buy RKLB's Dip? 

RKLB is also surging, last seen up 7% to trade at $20.33. The stock slipped below the 100-day moving average in late February, after staying above this trendline for most of the past year. While shares have taken a breather from their Jan. 24, record high of $33.34, RKLB rose 379.2% in the last 12 months.

LUNR Bounces Off Support

LUNR is up 2.1% to trade at $13.76 at last check, staging a bounce off a familiar floor at the $12 level, which contained December losses. The equity has distanced itself from its Jan. 27, two-year peak of $24.95, but the 140-day moving average lingers below, poised to stop additional losses. In the past nine months, LUNR added 156.6%.

The shares of healthcare name Hims & Hers Health Inc (NYSE:HIMS) have retreated from their Feb. 19, pre-earnings all-time high of $72.98. The stock has shed 11.9% so far this month, and is on track for its fourth loss in five sessions, last seen down 0.7% at $40.18. Despite this pullback, historical data suggests the security may be primed for a rebound.

Per a new study from Schaeffer's Senior Quantitative Analyst Rocky White, HIMS is now within one standard deviation of its 50-day moving average. Shares have traded north of this trendline 80% of the time over the past two months and in eight of the last 10 trading days.

Similar pullbacks have historically led to strong short-term upside, with past instances resulting in a one-month gain 71% of the time, averaging a 10.6% return. A comparable move would put Hims & Hers Health stock near $44, extending its impressive 176.3% year-over-year lead.

Short sellers are backing off, with short interest down 20.8% in the last reporting period. However, the 46.12 million shares sold short account for 24.6% of the equity's available float, indicating there's still room for a short squeeze. Analysts remain cautious, leaving room for upgrades to act as a bullish catalyst as well, with nine of 14 covering firms maintaining a "hold" or worse rating on HIMS.

Options traders also lean bearish, with Hims & Hers Health stock's Schaeffer's put/call open interest ratio (SOIR) of 1.47 sitting in the 94th percentile of readings from the past month. Echoing this, the equity's 50-day put/call volume ratio of 1.14 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) ranks in the 99th percentile of its annual range.

HIMS has consistently exceeded options traders' volatility expectations, as reflected in its Schaeffer’s Volatility Scorecard (SVS) score of 90 out of 100. This metric suggests the stock has historically delivered larger-than-expected price swings.

The Dow Jones Industrial Average (DJI) is trading near breakeven this afternoon, while the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are lower. Traders are digesting weak jobs data and tariffs, with Commerce Secretary Howard Lutnick's suggested trade deal with Canada and Mexico yet to come to fruition. A better-than-expected Institute for Supply Management (ISM) services index could be keeping today's losses in check, as President Donald Trump looks at which sectors could get relief from tariffs.

Continue reading for more on today's market, including: 

• Is it time to buy the dip on Palantir Technologies stock?
• Foot Locker stock brushes off disappointing revenue.
• Plus, options traders blast ANF; gold and oil stocks moving in opposite directions.

Abercrombie & Fitch Co (NYSE:ANF) stock is seeing unusual options activity today, with 16,000 calls and 31,000 puts traded so far today -- 8 times the volume typically seen at this point. The most active contract is the May 70 put, where positions are being opened. ANF was last seen off 15% at $81.70, brushing off the company's better-than-expected results for the fourth quarter after a dismal current-quarter and fiscal year outlook. The equity is on track for a third-straight daily loss and worst day since Jan. 13, and earlier hit a 52-week low of $79.77. So far in 2025, Abercrombie stock already shed 45.8%.

Freeport-McMoRan Inc(NYSE:FCX) stock is near the top of the SPX today, last seen up 7% at $37.33. Rising metal prices, a weaker U.S. dollar, and increasing demand for gold as traders turn to the safe-haven commodity during the trade war, are boosting the equity. FCX could snap its four-day losing streak with its best single-day percentage gain since September, but has yet to conquer the 40-day moving average on a bounce off yesterday's a 52-week low of $34.26.

Meanwhile, Marathon Petroleum Corp (NYSE:MPC) is one of the worst stocks on the SPX today, down 6.1% to trade at $133.87 at last glance. Tariffs and the Organization of the Petroleum Exporting Countries and its allies' (OPEC+) move to lift outputs dinged the shares. The oil stock is eyeing its worst single-day percentage drop since October, as well as its third-straight daily drop, while carrying a 23.2% year-over-year deficit.

AeroVironment, Inc. (NASDAQ:AVAV) is down 19.1% at $114.84 at last glance, following the defense contractor's fiscal third-quarter earnings miss and disappointing full-year guidance, with estimates of $780 to $795 million falling short of analysts' expected $820 million. As a key supplier of guided munitions to Ukraine, President Trump's wavering support is weighing on the shares as well. In response, Baird lowered its price target to $146 from $220. Trading at 52-week lows, AVAV is down 20.3% year over year. 

In the options pits, AVAV has already seen 2,232 calls and 2,179 puts traded, 13 times its average daily options volume. The weekly 3/21 160-strike call is the most active contract, with new positions being sold to open there. 

CrowdStrike Holdings Inc (NASDAQ:CRWD) stock is down 9.6% at $352.66 despite the cybersecurity name's better-than-expected fourth-quarter results, after current-quarter and full-year earnings guidance fell short of expectations. A slew of analysts have handed out both price target cuts and hikes in response. Trading at its lowest levels since late January as it falls from its Feb. 19 record high of $455.59, CRWD is still holding on to a 3% year-to-date lead, up 18.9% over the past 12 months. 

So far, CRWD has seen 44,000 calls and 53,000 puts exchanged, which 5 times the volume typically seen at this point. The weekly 3/7 320-strike put is the most popular, with new positions being opened there.